Patients taking benralizumab, dupilumab, or mepolizumab have lower postvaccination SARS-CoV-2 immunity. Runnstrom MC, Lamothe PA, Faliti CE, Cheedarla N, et al. J Allergy Clin Immunol 2024;154:435-446.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Runnstrom MC, Lamothe PA, Faliti CE, Cheedarla N, et al. Patients taking benralizumab, dupilumab, or mepolizumab have lower postvaccination SARS-CoV-2 immunity. J Allergy Clin Immunol 2024;154:435-446.
PMID: 38878020